Masimo | MASI - Current Assets


Masimo reported $926M in Current Assets for its fiscal quarter ending in December of 2025.





Current Assets Change Date
Abbott USD 26B 1.16B Dec/2025
Accuray USD 303.6M 13.86M Sep/2025
Align Technology USD 2.62B 82.47M Dec/2025
AngioDynamics USD 172.27M 3.09M Feb/2025
Artivion USD 358.08M 20.58M Dec/2025
AtriCure USD 322.52M 21.41M Dec/2025
Avanos Medical USD 355.4M 4M Dec/2025
Baxter International USD 6.87B 61M Dec/2025
Becton, Dickinson and Co. USD 9.19B 66M Dec/2025
Boston Scientific USD 8.79B 759M Dec/2025
Dexcom USD 4.03B 1.19B Dec/2025
Edwards Lifesciences USD 6.36B 218.3M Sep/2025
General Electric Aerospace USD 40.6B 522M Dec/2025
Globus Medical USD 2.13B 201.25M Dec/2025
Haemonetics USD 943.67M 43.99M Dec/2025
Inogen USD 203.72M 594K Sep/2025
Insulet USD 1.91B 54.6M Dec/2025
Integra LifeSciences USD 1.16B 15.96M Dec/2025
Intuitive Surgical USD 12.4B 927.3M Dec/2025
Masimo USD 926M 122.3M Dec/2025
Medtronic USD 24B 773M Sep/2025
Orthofix International USD 416.85M 22.68M Dec/2025
Owens Minor USD 547.87M 1.58B Dec/2025
ResMed USD 3.82B 193.06M Dec/2025
Steris USD 2.29B 179.9M Dec/2025
Stryker USD 14.76B 1.04B Dec/2025
Tandem Diabetes Care USD 618.14M 1.2M Dec/2025
Teleflex USD 1.94B 47.65M Dec/2025
Thermo Fisher Scientific USD 28.71B 6.41B Dec/2025
Zimmer Biomet Holdings USD 5.12B 715M Dec/2025